Methyl Alcohol

Methyl Alcohol

SCHEMBL5708979

CCCCCOCCCCC.CO

nearest known ligand 0.67

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.67
MEN1 O00255 1/20 0.67
THRB P10828 1/20 0.67
KMT2A Q03164 1/20 0.67
MAPT P10636 1/20 0.67
TSHR P16473 1/20 0.60
CES2 O00748 2/20 0.54
USP2 O75604 1/20 0.50
CES1 P23141 1/20 0.48
CA12 O43570 1/20 0.46
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
CA9 Q16790 1/20 0.46
ALDH1A1 P00352 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
LPAR3 Q9UBY5 4/20 0.44
LPAR2 Q9HBW0 3/20 0.44
LPAR1 Q92633 2/20 0.44
NAAA Q02083 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methyl Alcohol SCHEMBL19714946 0.97 HTT (0.71) HTTMEN1THRBKMT2AMAPT
Methyl Alcohol SCHEMBL19714845 0.97 HTT (0.71) HTTMEN1THRBKMT2AMAPT
Methyl Alcohol SCHEMBL19714948 0.97 HTT (0.71) HTTMEN1THRBKMT2AMAPT
Methyl Alcohol SCHEMBL19714915 0.97 HTT (0.71) HTTMEN1THRBKMT2AMAPT
Methyl Alcohol SCHEMBL19714871 0.97 HTT (0.71) HTTMEN1THRBKMT2AMAPT
Methyl Alcohol SCHEMBL19714937 0.97 HTT (0.71) HTTMEN1THRBKMT2AMAPT
Hexane SCHEMBL3260754 0.93 THRB (0.65) HTTMEN1THRBKMT2AMAPT
SCHEMBL8773 0.93 THRB (0.65) HTTMEN1THRBKMT2AMAPT
SCHEMBL9011679 0.93 THRB (0.65) HTTMEN1THRBKMT2AMAPT
SCHEMBL9011627 0.93 THRB (0.65) HTTMEN1THRBKMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117430510-A Preparation method of ethyl chrysanthemate 常州大学 2024-01-23 CN disclosed
EP-1708999-A1 BRONCHORELAXING COMPOUNDS RESPIRATORIUS AB (SE) 2006-10-11 EP disclosed
US-20060040919-A1 Bronchorelaxing compounds RESPIRATORIUS AB (SE) 2006-02-23 US disclosed
WO-2005070887-A1 BRONCHORELAXING COMPOUNDS RESPIRATORIUS AB (SE) 2005-08-04 WO disclosed
US-5679699-A ANTIISCHEMIC AGENTS, HEART RATE LOWERING AGENTS KALI-CHEMIE PHARMA GMBH (DE) 1997-10-21 US disclosed
US-5547967-A HYPOTENSIVE AGENT, ANTIISCHEMIC AGENT KALI-CHEMIE PHARMA GMBH (DE) 1996-08-20 US disclosed
US-5474988-A Analgesics, antiinflammatory agents KALI-CHEMIE PHARMA GMBH (DE) 1995-12-12 US disclosed
EP-0642345-A4 HALICHONDRINS AND RELATED COMPOUNDS. HARVARD COLLEGE (US) 1995-04-19 EP disclosed
EP-0642345-A1 HALICHONDRINS AND RELATED COMPOUNDS THE PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 1995-03-15 EP disclosed
US-5332733-A Antiallergens, antiinflammatory KALI-CHEMIE PHARMA GMBH (DE) 1994-07-26 US disclosed
US-5324725-A Antiinflammatory agent, antiallergen KALI-CHEMIE PHARMA GMBH (DE) 1994-06-28 US disclosed
US-5300695-A Reacting two alcohols to produce higher molecular weight alcohol using ion exchanged Zeolite L catalyst; intermediate for ether formation gasoline additive AMOCO CORPORATION (US) 1994-04-05 US disclosed
US-5283243-A Anti-inflammatory, anti-allergic, hypotensive and vasodilating agents KALI-CHEMIE PHARMA GMBH (DE) 1994-02-01 US disclosed
US-5272143-A 6-oxoazepinoindole compounds, and pharmaceutical compositions containing them KALI-CHEMIE PHARMA GMBH (DE) 1993-12-21 US disclosed
WO-1993017690-A1 HALICHONDRINS AND RELATED COMPOUNDS PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 1993-09-16 WO disclosed
US-4695566-A 3-aminocarbonylmethoxy-5-phenylpyrazole compounds, antiarrythmic compositions containing them, and intermediates in their preparation KALI-CHEMIE PHARMA GMBH (DE) 1987-09-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060040919-A1 Bronchorelaxing compounds CHRM3, GPR3, CHRM2 HTT 3953/4885MEN1 2210/4885THRB 1760/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.